Tiziana Life Sciences Announces Purchase of Shares by Chairman - Stock Titan
2025-05-12 • Google News
Tiziana Life Sciences Ltd (TLSA)
US$ 1.36-5.56%
Price Chart
Key Statistics
Market Cap
$ 171.77M
P/E Ratio
0.00
Revenue (TTM)
$ -3.6M
Volume
342.93K
52W High
$ 1.91
52W Low
$ 0.63
Dividend Yield
0.00%
Beta
0.11
Technicals
50-Day MA
1.4792
200-Day MA
1.0915
52 Week High
1.91
52 Week Low
0.6295
About TLSA
Tiziana Life Sciences Ltd, a biotechnology company, engages in the development of transformative therapies for neurodegenerative and lung diseases in the United States. The company's lead product cand.
Employees
9
Headquarters
London, United Kingdom
CEO
Mr. Gabriele Marco Antonio Cerrone M.B.A.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg